Board Meeting4 Aug 2026, 04:50 pm
Windlas Biotech Board Meeting on Aug 10 to Approve Q1 FY27 Results
AI Summary
Windlas Biotech Ltd has announced that its Board of Directors will convene on August 10, 2026. The primary agenda item is to consider and approve the un-audited standalone financial results for the first quarter ended June 30, 2026. In line with SEBI regulations, the company's trading window has been closed since July 1, 2026, and will reopen 48 hours after the financial results are declared. This meeting is a routine procedural step for financial reporting.
Key Highlights
- Board meeting scheduled for August 10, 2026.
- To approve un-audited standalone financial results for Q1 FY27.
- Trading window remains closed until results announcement.
- Adheres to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price Impact
More from WINDLAS*